Evidence map›Paper›PMID 26206753›Full record

SynthesisEndocrine2015

PET imaging in ectopic Cushing syndrome: a systematic review.

Prasanna Santhanam, David Taieb, Luca Giovanella, Giorgio Treglia

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Endocrine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Site-specific performance ofFrontiers in oncology · 2023
    Article
  4. Article
  5. Comparison of diagnostic efficacy ofFrontiers in endocrinology · 2022
    Article
  6. Head-to-head comparison ofEuropean journal of nuclear medicine and molecular imaging · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Functional imaging in ectopic Cushing syndrome.Current opinion in endocrinology, diabetes, and obesity · 2020
    Review
  11. Endocrine · 2020
    Article
  12. Review
  13. Article
  14. The Clinical Impact of [Clinical endocrinology · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Prasanna SanthanamSection of Endocrinology, Department of Internal Medicine, Joan C Edwards School of Medicine, Marshall University, Huntington, WV, 25701, USA. prasu14@yahoo.com.
David TaiebDepartment of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France. david.taieb@ap-hm.fr.
Luca GiovanellaNuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, Bellinzona and Lugano, Switzerland. luca.giovanella@eoc.ch.
Giorgio TregliaNuclear Medicine and PET/CT Center, Oncology Institute of Southern Switzerland, Bellinzona and Lugano, Switzerland. giorgio.treglia@eoc.ch.
Institute of Oncology Research · CHAix-Marseille Université · FRMarshall University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cushing syndrome due to endogenous hypercortisolism may cause significant morbidity and mortality. The source of excess cortisol may be adrenal, pituitary, or ectopic. Ectopic Cushing syndrome is sometimes difficult to localize on conventional imaging like CT and MRI. After performing a multilevel thoracoabdominal imaging with CT, the evidence regarding the use of radiotracers for PET imaging is unclear due to significant molecular and etiological heterogeneity of potential causes of ectopic Cushing's syndrome. In our systematic review of literature, it appears that GalLium-based (Ga68) somatostatin receptor analogs have better sensitivity in diagnosis of bronchial carcinoids causing Cushing syndrome and FDG PET appears superior for small-cell lung cancers and other aggressive tumors. Further large-scale studies are needed to identify the best PET tracer for this condition.

Indexed as

ACTH Syndrome, EctopicCushing SyndromeHumansPositron-Emission Tomography18F-FDGEctopic Cushing syndromeOctreoscanPET

Identifiers

PMID26206753
OpenAlexW980183604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.